Most material SEC filings — July 6, 2026

BioXcel Therapeutics (market cap ~$11M) executed its tenth amendment to its credit facility with Oaktree Capital and Q Boost Holding LLC (Qatar Investment Authority) on July 3, 2026. Key changes: deferred $9,016,914 payment due June 30 to July 31; reduced minimum liquidity requirement from $12.5M to $7.5M post-amendment; capitalized accrued interest and added 100 bps amendment fee (1% of outstanding principal) to loan balance; required board-approved Strategic Process Committee (independent director David Mack) with exclusive authority over sale, restructuring, bankruptcy, or equity raise; imposed strict operational controls including bi-weekly 13-week cash flow reporting, 15% variance cap on disbursements, ban on dividends/asset sales/IP transfers/compensation increases through July 31, weekly lender meetings, and requirement to enter definitive agreements for acceptable transaction by July 31 or face default; removed all transfer restrictions on lenders' loan interests.

Invivyd received FDA Notice of Termination for PEMGARDA's COVID-19 Emergency Use Authorization, effective June 29, 2027, following HHS termination of the COVID-19 EUA declaration. The company has a 12-month transition period and is in dialogue with FDA on next steps, stating it believes PEMGARDA has sufficient clinical data to support a full Biologics License Application (BLA) submission and approval. PEMGARDA, approved under EUA in March 2024 for pre-exposure prophylaxis in immunocompromised patients, is Invivyd's primary commercial product.

On July 2, 2026, Jet.AI stockholders voted 99% in favor (768,718 of 778,325 shares cast) to approve a merger with flyExclusive, Inc. The deal involves a spinoff of Jet.AI SpinCo, Inc., with existing Jet.AI shareholders retaining their shares and receiving merger consideration. The transaction is expected to close July 7, 2026, allowing Jet.AI to focus on AI infrastructure while flyExclusive expands its private aviation platform.

As of June 28, 2026, Bitmine holds 5,742,237 ETH valued at $10.3B (at $1,800/ETH), plus $527M cash/securities and other crypto, totaling $11.1B. The company closed a $273.8M net proceeds offering of 3.5M shares of Series A Preferred Stock at $80/share on June 10, 2026, now trading on NYSE under BMNP with weekly dividends at 9.50%. Bitmine was added to the Russell 1000 index on June 26, 2026, and operates 4.88M staked ETH generating annualized revenues of $235M ($277M projected at full staking).

Scilex (market cap ~$32.4M) signed a binding term sheet with iHolding Group LLP (Almaty, Kazakhstan) for a $100M strategic investment at $15/share, representing ~6.67M shares. The investment is contingent on due diligence completion, definitive agreement execution, board/stockholder/regulatory approvals, and would fund product development, acquisitions, working capital, and general corporate purposes. This represents a transformational capital infusion approximately 3× the company's current market capitalization.

Envirotech Vehicles, Inc. (public market cap ~$6.4M) merges with Azio AI Corporation (private) in a two-step transaction dated July 2, 2026. Azio AI shareholders receive 2,655,157 shares of Envirotech common stock (capped at 19.9% pre-transaction outstanding) plus 973,450 shares of convertible preferred stock (convertible 1:1000 into common, subject to shareholder vote). Two convertible notes of Azio AI ($150K aggregate principal) convert to Parent common stock. Post-closing, Envirotech's name changes to Azio AI Holdings, Inc.

Director VisionWave Holdings, Inc. (SVRE) bought 16934.7M shares (~$116.2B) on the open market (41% of holdings). Open-market insider purchase — historically a bullish signal.

TeraWulf executed a 20-year lease with Anthropic for its Justified Data campus in Kentucky, generating ~$19 billion in contracted revenue over the initial term with 401 MW capacity coming online in H2 2027. Simultaneously, TeraWulf sold its 50.1% ownership stake in the Abernathy Joint Venture to Fluidstack-led investor group, monetizing its ~$450 million investment 'at a premium' and recycling capital into wholly owned infrastructure. The Abernathy project (168 MW in Texas, established 2025) will remain under Fluidstack's operational control post-closing.

Middleby Corporation and newly formed Midera Food Processing, Inc. entered into a Separation and Distribution Agreement dated July 5, 2026, to separate Middleby's Food Processing Equipment Group operating segment into an independent public company. RemainCo will distribute all Midera shares pro-rata to Middleby shareholders at a 1:1 ratio (one Midera share per Middleby share). The transaction includes transfer of specified assets/liabilities to Midera, with Midera obtaining debt financing (SpinCo Financing Arrangements) and RemainCo retaining all intercompany liabilities not expressly allocated to Midera.

On June 30, 2026, Big Digital Energy, Inc. (market cap ~$6.5M) issued 16,700 shares of Series D Convertible Preferred Stock at $900/share ($15.03M aggregate subscription amount; 90% of $1,000 stated value) to purchaser Six Thirty AI, LLC. Each preferred share converts to common stock at 95% of 5-day VWAP (floor price $1.80), accrues 5% annual dividends (18% post-triggering event), carries a 4.99% beneficial ownership cap, and includes warrants to purchase 926,748 common shares at $10.81/share (120% of closing price prior day). Issuance triggered certificate of designations establishing senior liquidation preferences, broad anti-dilution rights, and extensive covenants including $5M minimum stockholders' equity requirement.

iPower Inc. (market cap ~$9.8M) issued a $2.0M Series A Senior Secured Convertible Note to an institutional investor on July 6, 2026. The note carries a 10% annual interest rate, converts at $2.39/share, matures July 6, 2028, and is secured by company collateral. An amendment to the underlying Securities Purchase Agreement increased total facility size from $28.2M to $30.2M and Series B notes from $21M to $23M; the investor received $5.184M in Series A notes and $1.816M in Series B notes in the initial close, with rights to $2M additional mandatory closing and up to $23M in optional closings. Proceeds are unrestricted for AI infrastructure, supply chain initiatives, and general corporate purposes.

Solstice Advanced Materials (SOLS) announced a definitive agreement to acquire Element Solutions Inc. (ESI) for approximately $14.5 billion including net debt assumption. Element shareholders receive $10.00 cash plus 0.500 Solstice shares per share (~$50.10 total, 15% premium to July 2, 2026 close). Combined entity will have ~$6.8B FY2025 revenue, $1.7B adjusted EBITDA (26% margin including $180M run-rate synergies). Transaction expected to close H1 2027, funded via $4.7B Goldman Sachs bridge commitment, new debt, and cash. Element shareholders will own ~44% of combined company post-close.

SK hynix Inc., South Korea's second-largest DRAM manufacturer (29.1% market share Q1 2026) and HBM leader (56.4% share), filed Amendment No. 2 to Form F-1 on July 6, 2026 for a US public offering of 17.79 million common shares via ADSs at US$158.14/ADS (based on KRX KOSPI trading price W2,425,000 on July 3, 2026). Cornerstone investors indicated interest in up to US$7 billion. Estimated net proceeds ~US$28 billion will fund W45.5 trillion in Korean fab construction (Yongin Fab 1, PT7 packaging plant) and W11.9 trillion in EUV scanner acquisitions through end-2027. Q1 2026: revenue W52.6 trillion (+198% YoY), profit W40.3 trillion (+397% YoY).

U.S. GoldMining has started drilling at its 100%-owned Whistler Gold-Copper Project in Alaska. The company has activated one drill ahead of schedule and a second is en route to test 8-10 high-priority targets within the Whistler Orbit district cluster. The 2026 program is fully funded for a minimum of 6,000 meters of core drilling, with first assay results expected by Q3 2026; this follows a March 2026 PEA modeling a $2.0 billion NPV5% for the primary Whistler deposit alone.

On July 2, 2026, CoreCivic sold its California City Detention Facility (2,560 beds; $732.6M) and Otay Mesa Detention Center (1,994 beds; $739.2M) to the U.S. Department of Homeland Security for a combined $1.5B gross price. After taxes (~$400M) and transaction costs, CoreCivic expects net proceeds of ~$1.1B, which it plans to use to repay $477.8M in debt (revolving credit, term loans, and 4.75% senior notes due Oct 2027), with remainder available for general corporate purposes including potential share repurchases and growth investments. CoreCivic may continue managing both facilities under existing ICE contracts through August 2027 (California City) and December 2029 (Otay Mesa, with 5-year extension option).

Maison Solutions Inc. agreed to sell assets of two loss-generating Asian grocery stores (San Gabriel and Monrovia, CA locations) to Enson Market entities (buyers Qinghui Ni, CEO) for $4.5M total ($2.25M each location: $2.24M assets + $10K beer/wine licenses), with inventory purchased separately. Closing expected by December 31, 2026. Payment structure: lump sum due by December 31, 2026, or if SBA financing fails, seller-financed via promissory notes at 10% interest (18% on default), with security interest in collateral and personal/corporate guaranty from Qinghui Ni and Enson Group Inc. Sellers retain right to payoff prior SBA COVID loans.

Verde Renewables entered a Master Commercialization and Collaboration Agreement with Ergon Asphalt Emulsions (effective July 1, 2026) establishing Verde as preferred vendor of engineered biochar for Ergon's cold paving products and other applications. The deal includes an initial project with target supply volumes (redacted), 50/50 carbon credit split, and a per-gallon royalty (redacted) on Ergon's emulsion sales. The 10-year initial term may renew for 5 additional years; either party may terminate with 6 months' notice at initial term expiration or upon material breach (with cure periods) or leadership change affecting Verde's CEO/COO.

Jolie Kahn resigned as CEO effective immediately on July 6, 2026. The Board appointed Pete Wylie, serving as Chief Operating Officer, as Interim CEO while continuing his COO duties. The Board has retained ZRG Partners to conduct a comprehensive search for a permanent CEO successor. No disagreement with company operations cited for departure.

Volato Group eliminated all outstanding convertible notes in Q2 2026, exiting the quarter with ~$8.4M cash and total liabilities (excluding deferred revenue) down 75% YoY to ~$5M. Vaunt marketplace posted record Q2 cash sales of $2.2M (199% YoY growth), with ARR projected at $4.7M (250% YoY growth) and 2,743 paid members (71% YoY growth). Management is pursuing a potential strategic merger targeted for Q3 2026 in AI infrastructure/software sectors.

Capstone Holding Corp. and investor Tumim Stone Capital, LLC amended their June 16, 2026 stock purchase agreement effective July 2, 2026. The amendment modifies the valuation period end time from 4:00:02 p.m. to 3:59:59 p.m. and redefines VWAP Purchase Price calculation to equal the greater of (i) the lowest traded price during the valuation period or (ii) 90% of VWAP (excluding opening and closing prints), subject to minimum price thresholds. The amendment applies prospectively to VWAP purchase notices delivered after July 2, 2026.

On July 1, 2026, Neolara Corp. (total assets ~$15K) entered a non-binding letter of intent to potentially acquire a Hong Kong-based AI-driven photo restoration and image enhancement company for 100% of equity or substantially all assets. No purchase price, financing terms, or deal timeline were disclosed. The transaction is non-binding, subject to due diligence, definitive agreement negotiation, regulatory approval, and customary closing conditions with no assurance of completion.

Solstice Advanced Materials agreed to acquire Element Solutions Inc. in a cash-and-stock transaction valued at approximately $14.5 billion (including assumed net debt), announced July 6, 2026. Element shareholders receive $10.00 cash plus 0.500 Solstice shares per Element share (~$50.10/share, 15% premium to July 2 close). Combined FY2025 pro forma revenue ~$6.8B, adjusted EBITDA $1.7B (26% margin including $180M run-rate synergies). Transaction expected to close H1 2027 pending regulatory and shareholder approvals; Solstice funded by $4.7B Goldman Sachs bridge commitment plus new debt and cash on hand; expected net leverage 3.5x at close, delevering below 3x within 18 months.

Cosmos Health's Board authorized a share repurchase program of up to $5 million through December 31, 2026. The repurchase will occur in open market, private transactions, or other permitted means under SEC rules. CEO stated the program represents ~50% of the company's $9.5M market cap as of June 29, 2026, reflecting confidence in operating fundamentals and belief that shares are undervalued.

On July 29, 2024, Synergy Empire Limited (SHMY, Nevada-incorporated shell company with ~$2K assets) agreed to acquire 100% of Meluha Therapeutics Berhad (Malaysian biotech, ~$2.2K assets) by issuing 10,000,000 shares of Series A Preferred Stock at $0.2155/share ($2,155,000 aggregate). The acquisition closed March 28, 2025. Meluha shareholders (Ramesh A/L Saravanamuthu 33.6%, Abdul Jalil bin Jidon 31.9%) received preferred shares and will control 56.8% combined voting power post-close. This is a reverse recapitalization; Meluha is the accounting acquirer. Meluha manufactures cell-based therapeutics (myCell, Chondrogen) targeting osteoarthritis in Malaysia; FY2024 revenue $1.006M, net income $667K; 9M FY2025 revenue $1.253M, net income $194K. Going concern doubt noted due to $1.9M accumulated deficit and negative working capital.

Bespoke Extracts amended its December 2024 Senior Secured Promissory Note on June 30, 2026, extending maturity from June 30 to August 14, 2026 (45 days), raising interest from 15% to 17% p.a. for the extension period, and issuing common shares equal to 10% of outstanding principal (valued at 10-day VWAP ending June 30, 2026) within 30 days. The amendment binds all noteholders under Simple Majority consent provisions. Original principal amount and holder identity are not disclosed in the exhibit.

Clarivate entered a definitive agreement to divest its Life Sciences & Healthcare (LS&H) segment to Altaris LLC for $600 million ($500M cash at closing, $25M deferred, $75M seller note). Proceeds will be used to reduce debt. The transaction is expected to close by year-end 2026. Post-divestiture, Clarivate will focus on Academia & Government and Intellectual Property segments; LS&H segment will take ~$225–$250M non-cash goodwill impairment. The company reaffirmed 2026 full-year guidance and projects improved Adj. EBITDA margin (+200 bps to ~42.75%), higher recurring revenue mix (+300 bps to ~92%), and maintained free cash flow (~$380M vs. $400M prior midpoint).

Unum Life Insurance Company of America ceded $3.8 billion of individual long-term care statutory reserves (26% of total LTC reserves, 52% of individual LTC reserves) representing approximately 50,000 policies to Fortitude Reinsurance Company Ltd. on a coinsurance basis, effective 2026. Combined with a prior 2025 LTC transaction, cumulative LTC reserve reduction exceeds $7 billion (~40% of total LTC reserves). Post-transaction, Unum retains ~$11 billion LTC statutory reserves (70% group LTC); holding company liquidity expected $1.5–$2.0B, leverage ~25%, RBC 400–425%. Transaction impact on operating earnings limited to foregone investment income and incremental interest expense.

Splash Beverage Group secured exclusive worldwide rights to CannEpil (cannabinoid-based drug-resistant epilepsy therapy) from Argent BioPharma Limited. Consideration: $5.5M in newly issued preferred equity, $5M debt forgiveness by Mercer Street Global, and a $1M strategic investment from C/M Capital Partners. Argent retains 15% net revenue royalty; agreement spans 20 years and covers all territories. CannEpil already has FDA pre-IND engagement, Irish reimbursement access (HSE), and UK Named Patient authorization.

Liminatus Pharma agreed to acquire InnocsAI LLC, a CAR-T therapy technology company, by issuing 1,600,000,000 common shares at $0.20/share (nominal $320M equity value) plus contingent value rights representing 20% of net proceeds from future strategic exits. Shares capped at 19.99% of Liminatus' pre-transaction outstanding; excess consideration paid in convertible preferred stock (160,000 shares, 10,000:1 conversion ratio) requiring stockholder approval. Closing targeted December 31, 2026, contingent on regulatory approvals and Nasdaq listing maintenance.

Figure Technology Solutions announced a private offering of $600 million aggregate principal amount of senior notes (Rule 144A/Reg S exempt offering) on June 6, 2026. Net proceeds will fund cash consideration for the Kiavi acquisition (an AI-powered residential real estate lending platform), general corporate purposes, and offering fees. The notes will be guaranteed by certain domestic wholly-owned subsidiaries; offering completion is not conditioned on Kiavi acquisition closing.

The Middleby Corporation (RemainCo) and Midera Food Processing, Inc. (SpinCo) entered into a Separation and Distribution Agreement dated July 5, 2026, to effect a tax-free spin-off. Middleby will distribute all outstanding shares of Midera common stock pro rata (1:1 ratio) to Middleby shareholders. The separation includes transfer of Midera's assets and assumption of its liabilities, with Midera to obtain debt financing (SpinCo Financing Arrangements) and make a cash distribution to Middleby. Middleby retains sole discretion to determine distribution date and may abandon the transaction.